
浏览全部资源
扫码关注微信
400037 重庆, 第三军医大学新桥医院内分泌科
[ 郑宏庭, E-mail:fnf7703@hotmail.com ZHENG Hongting, E-mail:fnf7703@hotmail.com
[ 隆敏, E-mail:longmin_casper@163.com LONG Min, E-mail:longmin_casper@163.com
收稿:2017-04-05,
修回:2017-07-03,
纸质出版:2017-10-15
移动端阅览
蔡雷琴, 李文杰, 隆敏, 等. 局部应用肉桂醛通过激活Nrf2通路促进糖尿病小鼠创口愈合[J]. 第三军医大学学报, 2017,39(19):1906-1912.
Leiqin CAI, Wenjie LI, Min LONG, et al. Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway[J]. Journal of Third Military Medical University, 2017, 39(19): 1906-1912.
蔡雷琴, 李文杰, 隆敏, 等. 局部应用肉桂醛通过激活Nrf2通路促进糖尿病小鼠创口愈合[J]. 第三军医大学学报, 2017,39(19):1906-1912. DOI: 10.16016/j.1000-5404.201704153.
Leiqin CAI, Wenjie LI, Min LONG, et al. Topical administration of cinnamic aldehyde accelerates wound healing in diabetic mice by activation of Nrf2 pathway[J]. Journal of Third Military Medical University, 2017, 39(19): 1906-1912. DOI: 10.16016/j.1000-5404.201704153.
目的
2
探讨局部应用肉桂醛(cinnamic aldehyde
CA)对糖尿病小鼠创口愈合的影响及其机制。
方法
2
8周龄Nrf2野生型(Nrf2
+/+
)和Nrf2敲除型(Nrf2
-/-
)雄性SKH-1无毛小鼠各8只
持续5 d腹腔注射链脲霉素(streptozotocin
STZ
50 mg/kg)
建立糖尿病小鼠模型。采用随机数字表法分为:① Nrf2
+/+
鼠对照组(Nrf2
+/+
Veh组); ② Nrf2
+/+
鼠CA治疗组(Nrf2
+/+
CA组); ③ Nrf2
-/-
鼠Veh组(Nrf2
-/-
Veh组); ④ Nrf2
-/-
鼠CA组(Nrf2
-/-
CA组)(
n
=4)。STZ注射后第4周,在小鼠背部建立直径6 mm的全层皮肤切除创口。Nrf2
+/+
CA组和Nrf2
-/-
CA组术后当日开始局部应用20 μL含4 μmol/L CA的聚乙二醇400(polyethylene glycol400
PEG400)
每隔1天干预直至第14天
收集创缘处皮肤
Nrf2
+/+
Veh组和Nrf2
-/-
Veh组采用20 μL PEG400(Vehicle
Veh)局部应用作为空白对照。术后2周内每隔1天监测皮肤创口愈合面积评估愈合速率。免疫组化染色对比各组创缘处皮肤组织Nrf2蛋白、下游靶蛋白HO-1和氧化应激损伤相关指标8-oxo-dG的表达水平。
结果
2
局部应用CA明显加速Nrf2
+/+
糖尿病小鼠创口愈合(
P
<
0.05)
但是并不影响Nrf2
-/-
糖尿病小鼠创口愈合(
P
>
0.05)。免疫组化示Nrf2
+/+
糖尿病溃疡小鼠局部应用CA后
其创缘皮肤Nrf2的表达水平[(2.42±0.29)
vs
(7.42±0.73)
P
<
0.05
]
和下游靶蛋白HO-1的表达水平[(5.92±0.36)
vs
(8.88±0.53)
P
<
0.05
]
显著增强
8-oxo-dG的表达水平则明显减少[(9.46±0.28)
vs
(8.46±0.23)
P
<
0.05
]
。Nrf2
-/-
糖尿病小鼠创口局部外用CA后
其创缘处皮肤Nrf2、HO-1及8-oxo-dG的表达水平与Nrf2
-/-
Veh组相比并无明显变化。
结论
2
局部应用CA通过激活糖尿病小鼠皮肤组织Nrf2通路
减轻氧化应激损伤
从而促进糖尿病创口愈合。
Objective
2
To determine the effect of topical administration of cinnamic aldehyde (CA) on wound healing in diabetic mice
and investigate the underlying mechanism.
Methods
2
A total of 8 Nrf2
+/+
and 8 Nrf2
-/-
male hairless SKH-1 mice (8 weeks old) were intraperitoneally injected with streptozotocin (STZ
50 mg/kg) for 5 consecutive days to establish diabetic model. The mice were randomly divided into 4 groups: control group of Nrf2
+/+
mice (Nrf2
+/+
Veh)
CA treatment group of Nrf2
+/+
mice (Nrf2
+/+
CA)
control group of Nrf2
-/-
mice (Nrf2
-/-
Veh)
and CA treatment group of Nrf2
-/-
mice (Nrf2
-/-
CA) (
n
=4 for each group). In 4 weeks after STZ injection
2 full-thickness wounds (6 mm in size) were made on the back of the mice. From the day after surgery
Nrf2
+/+
CA and Nrf2
-/-
CA groups received topical administration with 20 μL 4 μmol/L CA diluted by polyethylene glycol 400 (PEG 400) every other day until skin tissues were harvested at the 14th day post-surgery
and Nrf2
+/+
Veh and Nrf2
-/-
Veh groups were given 20 μL PEG 400 as control. Meanwhile
the wound closure rates were monitored and assessed in 2 weeks post-surgery. The expression levels of Nrf2
downstream target protein HO-1
and 8-oxo-2'-deoxyguanosine (8-oxo-dG
a sensitive parameter for oxidative stress) in the skin of each group were assessed by immunohistochemistry.
Results
2
Topical administration of CA significantly accelerated the wound healing of Nrf2
+/+
diabetic mice (
P
<
0.05)
but had no such effect on the Nrf2
-/-
CA group (
P
>
0.05). Moreover
the expression levels of Nrf2 (2.42±0.29
vs
7.42±0.73
P
<
0.05) and HO-1 (5.92±0.36
vs
8.88±0.53
P
<
0.05) were increased
while the level of 8-oxo-dG (9.46±0.28
vs
8.46±0.23
P
<
0.05) was decreased at the wound site after CA treatment in Nrf2
+/+
diabetic mice. However
in the Nrf2
-/-
diabetic mice
CA treatment showed no effect on the expression levels of Nrf2
HO-1 and 8-oxo-dG.
Conclusion
2
Topically application of CA promotes diabetic wound healing
via
activation of Nrf2 pathway and alleviation of oxidative damage.
SCHAPER N C, APELQVIST J, BAKKER K. Reducing lower leg amputations in diabetes: a challenge for patients, healthcare providers and the healthcare system[J]. Diabetologia, 2012, 55(7): 1869-1872.DOI:10.1007/s00125-012-2588-z.
CAVANAGH P R, LIPSKY B A, BRADBURY A W, et al . Treatment for diabetic foot ulcers[J ] . Lancet, 2005, 366(9498): 1725-1735.DOI:10.1016/S0140-6736(05)67699-4.
ELDOR R, RAZ I, BEN Y A, et al . New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies[J ] . Diabet Med, 2004, 21(11): 1161-1173.DOI:10.1111/j.1464-5491.2004.01358.x.
SCHAFER M, WERNER S. Oxidative stress in normal and impaired wound repair[J]. Pharmacol Res, 2008, 58(2): 165-171.DOI:10.1016/j.phrs.2008.06.004.
JARAMILLO M C, ZHANG D D. The emerging role of the Nrf2-Keap1 signaling pathway in cancer[J]. Genes Dev, 2013, 27(20): 2179-2191.DOI:10.1101/gad.225680.113.
LONG M, ROJO DE LA VEGA M, WEN Q, et al . An Essential Role of NRF2 in Diabetic Wound Healing[J ] . Diabetes, 2016, 65(3): 780-793.DOI:10.2337/db15-0564.
SOARES M A, COHEN O D, LOW Y C, et al . Restoration of Nrf2 Signaling Normalizes the Regenerative Niche[J ] . Diabetes, 2016, 65(3): 633-646.DOI:10.2337/db15-0453.
李文杰, 蔡雷琴, 隆敏, 等.肉桂醛促进高糖条件下皮肤成纤维细胞迁移及机制研究[J].第三军医大学学报, 2017, 39(5): 423-429. DOI:10.16016/J.10005404.201608082.
LI W J, CAI L Q, LONG M, et al . Cinamic aldehyde improves fibroblasts migration under hyperglycemic condition and its underlying mechanism[J ] . J Third Mil Med Univ, 2017, 39(5): 423-429. DOI:10.16016/J.10005404.201608082.
PHATAK U P, PASHANKAR D S. Role of Polyethylene Glycol in Childhood Constipation[J]. Clinical Pediatrics, 2014, 53(10): 927-932.DOI:10.1177/0009922813505699.
DINKOVA-KOSTOVA A T, JENKINS S N, FAHEY J W, et al . Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts[J ] . Cancer Letters, 2006, 240(2): 243-252.DOI:10.1016/j.canlet.2005.09.012.
FRANKLIN S J, DICKINSON S E, KARLAGE K L, et al . Stability of sulforaphane for topical formulation[J ] . Drug Dev Ind Pharm, 2014, 40(4): 494-502.DOI:10.3109/03639045.2013.768634.
ZHENG H, WHITMAN S A, WU W, et al . Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy[J ] . Diabetes, 2011, 60(11): 3055-3066.DOI:10.2337/db11-0807.
LONG M, TAO S, ROJO DE LA VEGA M, et al . Nrf2-Dependent Suppression of Azoxymethane/Dextran Sulfate Sodium-Induced Colon Carcinogenesis by the Cinnamon-Derived Dietary Factor Cinnamaldehyde[J ] . Cancer Prev Res(phila), 2015, 8(5): 444-454.DOI:10.1158/1940-6207.CAPR-14-0359.
KARRI V V, KUPPUSAMY G, TALLURI S V, et al . Current and emerging therapies in the management of diabetic foot ulcers[J ] . Curr Med Res Opin, 2016, 32(3): 519-542.DOI:10.1185/03007995.2015.1128888.
JEFFCOATE W J, HARDING K G. Diabetic foot ulcers[J]. Lancet, 2003, 361(9368): 1545-1551.DOI:10.1016/S0140-6736(03)13169-8.
HAYES J D, DINKOVA-KOSTOVA A T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism[J]. Trends Biochem Sci, 2014, 39(4): 199-218.DOI:10.1016/j.tibs.2014.02.002.
KNATKO E V, IBBOTSON S H, ZHANG Y, et al . Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans[J ] . Cancer Prev Res (Phila), 2015, 8(6): 475-486.DOI:10.1158/1940-6207.CAPR-14-0362.
KERNS M L, GUSS L, FAHEY J, et al . Randomized, split-body, single-blinded clinical trial of topical broccoli sprout extract: Assessing the feasibility of its use in keratin-based disorders[J ] . J Am Acad Dermatol, 2017, 76(3): 449-453.DOI:10.1016/j.jaad.2016.10.009.
FRIEDMAN M, KOZUKUE N, HARDEN L A. Cinnamaldehyde content in foods determined by gas chromatography-mass spectrometry[J]. J Agric Food Chem, 2000, 48(11): 5702-5709.DOI: 10.1021/jf000585g.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621